Etanercept and demyelinating disease in a patient with psoriasis
- 31 January 2006
- journal article
- case report
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 54 (1) , 160-164
- https://doi.org/10.1016/j.jaad.2005.05.039
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Successful rechallenge with anti–tumor necrosis factor α for psoriatic arthritis after development of demyelinating nervous system disease during initial treatment: Comment on the article by Mohan et alArthritis & Rheumatism, 2002
- Rheumatoid arthritis and its animal models: the role of TNF-α and the possible absence of specific immune reactionsCurrent Opinion in Immunology, 1999
- Tumor necrosis factor‐a and the progression of diabetes in non‐obese diabetic miceImmunological Reviews, 1999
- Oligodendrocyte Apoptosis and Primary Demyelination Induced by Local TNF/p55TNF Receptor Signaling in the Central Nervous System of Transgenic MiceThe American Journal of Pathology, 1998
- The role of TNFα and related cytokines in the development and function of the autoreactive T-cell repertoireResearch in Immunology, 1997
- TNF-α receptor fusion protein prevents experimental auto-immune encephalomyelitis and demyelination in Lewis rats: an overviewJournal of Neuroimmunology, 1997
- Human tumor necrosis factor-α augments experimental allergic encephalomyelitis in ratsJournal of Neuroimmunology, 1991
- Anti—tumor necrosis factor therapy abrogates autoimmune demyelinationAnnals of Neurology, 1991
- An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis.The Journal of Experimental Medicine, 1990
- Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitroAnnals of Neurology, 1988